期刊文献+

异源性Th表位修饰的CTLA4-Ig-msBlys构建及融合蛋白表达

Construction and expression of a recombinant expression protein of CTLA4-Ig-msBlys which modified by Th epitope
下载PDF
导出
摘要 目的构建异源性Th表位修饰的CTLA4-Ig-msBlys的原核表达质粒,并在E.coliBL21中诱导融合蛋白表达,初步检测蛋白特性。方法采用PCR法从质粒pCMV-sBlys扩增sBlys片段,将与卵清蛋白(ovalbumin,OVA)Th表位重组后的msBlys连接CTLA4-Ig片段,克隆入pGEX-KG原核表达载体,用LB固体培养基抗生素筛选、酶切并经琼脂糖凝胶电泳鉴定;将质粒pGEX-KG-CTLA4-Ig-msBlys转入E.coliBL21菌株中,实现插入基因的融合表达,用SDS-PAGE和Western-blot检测表达产物。结果 pGEX-KG-CTLA4-Ig-msBlys构建正确且最终转入E.coliBL21,得到融合蛋白的表达;CTLA4-Ig-msBlys融合蛋白在E.coli中获得表达,表达产物的相对分子质量同预期值一致。结论成功构建原核表达质粒pGEX-KG-CTLA4-Ig-msBlys,并在E.coliBL21表达CTLA4-Ig-msBlys融合蛋白,为下一步探讨Blys在自身免疫性疾病患者的治疗作用奠定了基础。 Objective To construct the prokaryotic expression plasmid pGEX-KG-CTLA4-Ig-msBIys and its expression in E. coli BL21-To detect the fusion protein. Methods The DNA fragment of msBlys gene amplified from the plasmid pCMV- sBlys by polymerase chain reaction (PCR), then connected with OVA and CTLA4-Ig fragment. The DNA fragment of CTLA4- Ig-msBlys was cloned into the prokaryotic expression vector pGEX-KG and expressed as a fusion protein in E. coli BL21 induced by IPTG. The expressed fusion protein CTLA4-Ig-msBlys was purified and identified by SDS-PAGE and Western blot. Results The recombinant expression plasmid pGEX-KG-CTLA4-Ig-msBlys was successfully constructed. The recombinant expression protein was steadily expressed in E. coli, the relative molecular mass of the expression product was identical with the value pre- dicted. Conclusion The recombinant prokaryotic expression plasmid pGEX-KG-CTLA4-Ig-msBlys is constructed successfully transformed into E. coli BL21, then its expressed as a fusion protein CTLA4-Ig-msBlys in E. coli BL21. All that will be helpful for the further study of Blys.
出处 《福建医药杂志》 CAS 2011年第2期12-16,共5页 Fujian Medical Journal
基金 福建省自然科学基金项目(2008J0266) 福建省卫生厅青年科研课题(2008-1-16)
关键词 BLYS CTLA4-IG TH表位 融合蛋白 Blys CTLA4-Ig Th epitope fusion protein
  • 相关文献

参考文献14

  • 1Wang H, Marsters SA, Baker T, et al. TACI-ligand interac tions are required for T cell activation and collagen induced ar- thritis in mice [J]. Nat Immunol, 2001, 2 (7) : 632.
  • 2Mackay F, Sierro F, Grey ST, et al. The BAFF/APRIL system: an important player in systemic rheumatic diseases [J]. Curr Dir Autoimmun, 2005, 8: 243-265.
  • 3Ramanujam M, Davidson A. The current status of targeting BAFF/BLyS for autoimmune diseases [J]. Arthritis Res Ther, 2004, 6 (5): 197.
  • 4Haselfne WA. Oenomics and drug discovery [J]. J Am Aead Dermatol, 2001, 45 (3): 473-475.
  • 5Stohl W. A therapeutic role for BLyrS antagonists [J]. Lu-- pus, 2004, 13 (5): 317-3-22.
  • 6Kalled S L. BAFF: a novel the rapeutic target for autoimmu- nity [ J ]. Curr Opin Investig Drugs, 2002, 3 ( 7 ):1005-1010.
  • 7Baker KP. Blys-an essential survival factor for B cells: ba- siebiology, links to pathology and therapeutic target [J]. Au- toimmun Rev, 2004, 3 (5): 368-375.
  • 8Dalum I, Bufer MD, Jensen MR, et al. Therapeutic antibod- ies elicited by immunizafon against TNF-α [J]. Nat Biotechn- ol, 1999, 17 (7): 666-669.
  • 9Chambers CA, Krummel MF, Boitel B, et al. The role of the CTLA4 in the regulation and initiation of T cell responses [J]. Immunol Rev, 1996, 153 (1): 27-46.
  • 10Khare SD, Sarosi I, Xia XZ, et al. Severe B cell hyperplasia and autoimmtme disease in TALL-1 transgenicmice [J]. Proc Natl Acad Sci USA, 2000, 97 (7): 3370-3375.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部